Posted On: 09/20/2014 12:16:04 AM
Post# of 30035
Right
Amarantus Acquires Exclusive Option to License Intellectual Property for Use of MANF and CDNF to Treat Antibiotic-Induced Ototoxicity
http://www.globenewswire.com/news-release/201...ml?print=1
Amarantus Acquires Exclusive Option to License Intellectual Property for Use of MANF and CDNF to Treat Antibiotic-Induced Ototoxicity
http://www.globenewswire.com/news-release/201...ml?print=1
(0)
(0)Scroll down for more posts ▼
